- Home
- RVMD vs ASND Comparison
RVMD vs ASND Comparison
Compare RVMD & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | ASND |
|---|---|---|
| Founded | 2014 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.2B | 12.8B |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | RVMD | ASND |
|---|---|---|
| Price | $120.31 | $206.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 16 |
| Target Price | $81.19 | ★ $262.38 |
| AVG Volume (30 Days) | ★ 4.8M | 618.3K |
| Earning Date | 02-25-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $758,592,045.00 |
| Revenue This Year | N/A | $99.54 |
| Revenue Next Year | $714.50 | $84.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 97.46 |
| 52 Week Low | $29.17 | $118.03 |
| 52 Week High | $124.49 | $229.94 |
Technical Indicators
Market Signals| Indicator | RVMD | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 84.18 | 46.61 |
| Support Level | $76.28 | $188.08 |
| Resistance Level | $121.62 | $221.75 |
| Average True Range (ATR) | 6.23 | 10.08 |
| MACD | 3.36 | -0.09 |
| Stochastic Oscillator | 91.87 | 53.52 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.